Kei Kanie
Overview
Explore the profile of Kei Kanie including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Okamoto M, Matsumoto S, Sugiyama A, Kanie K, Watanabe M, Huang H, et al.
Polymers (Basel)
. 2020 Apr;
12(4).
PMID: 32316615
Vital pulp therapy is an important endodontic treatment. Strategies using growth factors and biological molecules are effective in developing pulp capping materials based on wound healing by the dentin-pulp complex....
12.
Sekimoto A, Kanemaru Y, Okano Y, Kanie K, Kato R, Kino-Oka M
Regen Ther
. 2020 Jan;
12:83-87.
PMID: 31890770
In order to produce high-quality cells in a static culture, the initial placement of the cells is one of the most important factors. Dense distribution of the cells increases the...
13.
Kanie K, Sasaki H, Ikeda Y, Tamada M, Togawa F, Kato R
Regen Ther
. 2020 Jan;
12:43-54.
PMID: 31890766
Introduction: Although cell culture has been widely used in the life sciences, there are still many aspects of this technique that are unclear. In this study, we have focused on...
14.
Kanie K, Sakai T, Imai Y, Yoshida K, Sugimoto A, Makino H, et al.
Regen Ther
. 2020 Jan;
12:27-35.
PMID: 31890764
The development of induced pluripotent stem cell (iPSC) techniques has solved various limitations in cell culture including cellular proliferation and potency. Hence, the expectations on wider applications and the quality...
15.
Yoshida K, Okada M, Nagasaka R, Sasaki H, Okada M, Kanie K, et al.
J Biosci Bioeng
. 2019 Feb;
128(2):209-217.
PMID: 30738731
Increasing the yield and maintaining a high quality of induced pluripotent stem cells (iPSCs) is necessary for manufacturing iPSCs at the industrial scale. However, because iPSCs are delicate, it is...
16.
Imai Y, Yoshida K, Matsumoto M, Okada M, Kanie K, Shimizu K, et al.
Regen Ther
. 2018 Dec;
9:15-23.
PMID: 30525071
Introduction: Advancing industrial-scale manufacture of cells as therapeutic products is an example of the wide applications of regenerative medicine. However, one bottleneck in establishing stable and efficient cell manufacture is...
17.
Nagasaka R, Matsumoto M, Okada M, Sasaki H, Kanie K, Kii H, et al.
Regen Ther
. 2018 Oct;
6:41-51.
PMID: 30271838
From the recent advances, there are growing expectations toward the mass production of induced pluripotent stem cells (iPSCs) for varieties of applications. For such type of industrial cell manufacturing, the...
18.
Ishikawa K, Yoshida K, Kanie K, Omori K, Kato R
SLAS Discov
. 2018 Aug;
24(1):47-56.
PMID: 30102873
The development of new drugs depends on the efficiency of drug screening. Phenotype-based screening has attracted interest due to its considerable potency for the discovery of first-in-class drugs. In general,...
19.
Hibi T, Ohtsuka H, Shimasaki T, Inui S, Shibuya M, Tatsukawa H, et al.
Genes Cells
. 2018 Jun;
PMID: 29900664
Most antiaging factors or life span extenders are associated with calorie restriction (CR). Very few of these factors function independently of, or additively with, CR. In this study, we focused...
20.
Shibuta M, Tamura M, Kanie K, Yanagisawa M, Matsui H, Satoh T, et al.
J Biosci Bioeng
. 2018 Jun;
126(5):653-660.
PMID: 29895430
Cellular morphology on and in a scaffold composed of extracellular matrix generally represents the cellular phenotype. Therefore, morphology-based cell separation should be interesting method that is applicable to cell separation...